Skip to Content

Tag: Restless Leg Syndrome (RLS)


Resmed taps RLS market for accretive growth

Vendors

Resmed taps RLS market for accretive growth

May 1, 2026Liz Beaulieu, Editor

SAN DIEGO – Resmed will buy Noctrix Health, the Pleasanton, Calif.-based developer of the Nidra Tonic Motor Activation therapy for restless leg syndrome (RLS), for $340 million in a move that leverages its existing sleep physician referral network and home medical equipment (HME) delivery channel. Nidra, which delivers electrical stimulation to the peroneal nerves via a pair of leg-word devices, was authorized for marketing in the United States in 2023, following its designation as a “breakthrough...

Mick Farrell, Noctrix Health, ResMed, Restless Leg Syndrome (RLS)


Read Full Articlered right arrow icon